# The National Cardiovascular Health Program (93.426)

Source: https://welltoldgrants.com/programs/93-426-the-national-cardiovascular-health-program/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

The National Cardiovascular Health Program is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $278 million in 123 grants, about $2.3 million per award.

## Objectives

This program supports extensive scientific evidence, links nonmedical factors, including systemic racism and the lack of economic opportunities, with poor health outcomes and increased mortality rates, all of which are preventable. Factors such as poverty, inadequate housing, poor health care, and other debilitating social conditions, commonly referred to as social determinants of health, contribute to long-standing disparities and health inequities.
These social conditions contribute to the increased prevalence of cardiovascular disease (CVD) in the US population. CVD is the leading cause of death in the US; stroke is the 5th leading cause. In 2020, about 1 in 5 adults who died from CVD were younger than 65 years old. It is estimated that 1 in 9 health care dollars are spent on CVD.
CVD mortality rates declined for several decades due to both clinical and public health interventions, but recently declining death rates from both heart disease and stroke have stalled. One reason is that hypertension, the primary risk factor for CVD, is very common (1 in 2 US adults has hypertension) but control is not. Only 1 in 4 adults with hypertension (26.1%) has it under control.
Gains have been made in treating high cholesterol, another primary risk factor for CVD. Overall, the age-adjusted prevalence of high cholesterol decreased from 21% to 10% from 1988–1994 to 2017–2018. This improvement is due in part to individuals’ healthy behaviors such as eating a healthy diet, losing weight, being physically active, and medication adherence, along with clinical contributions from appropriate prescribing and intensification of medication. Additional public health and health system interventions aimed at preventing, detecting, and controlling elevated cholesterol and blood pressure can help to further decrease CVD mortality.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $110 million | 51 |
| 2022 | $91.8 million | 51 |
| 2023 | $76.0 million | 72 |
| 2024 | $0 | 0 |
| 2025 | $0 | 0 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| California Department of Public Health | California | $9.1 million |
| Department of State Health Services | Texas | $7.9 million |
| Health Research, Inc. | New York | $7.7 million |
| Michigan Department of Health and Human Services | Michigan | $7.0 million |
| Virginia Department of Health | Virginia | $6.4 million |
| Minnesota Department of Health | Minnesota | $6.1 million |
| State of Georgia Department of Public Health | Georgia | $6.1 million |
| Ohio Department of Health | Ohio | $6.0 million |
| Massachusetts Department of Public Health | Massachusetts | $6.0 million |
| Pennsylvania Department of Health | Pennsylvania | $5.9 million |
| Florida Department of Health | Florida | $5.9 million |
| Arizona Department of Health Services | Arizona | $5.9 million |
| District of Columbia, Government of | District of Columbia | $5.9 million |
| Health Services Kentucky Cabinet for | Kentucky | $5.8 million |
| State of Wisconsin Department of Health Services | Wisconsin | $5.8 million |
| North Carolina Department of Health & Human Services | North Carolina | $5.7 million |
| South Carolina Department of Public Health | South Carolina | $5.5 million |
| West Virginia Department of Health and Human Resources | West Virginia | $5.5 million |
| Alabama Department of Health | Alabama | $5.5 million |
| Department of Public Health Illinois | Illinois | $5.5 million |